Skip to main content
. 2023 Feb 11;20(4):3176. doi: 10.3390/ijerph20043176
CEAC Cost-effectiveness acceptability curve
CRNM bleeding Clinically relevant non-major bleeding
CTEPH Chronic thromboembolic pulmonary hypertension
DOAC Direct oral anticoagulants
DVT Deep vein thrombosis
GI bleeding Gastrointestinal bleeding
ICER Incremental cost-effectiveness ratio
ICH Intracranial hemorrhage
PE Pulmonary embolism
QALY Quality-adjusted life years
THB Thai bath
USD US dollars
VTE Venous thromboembolism
WTP Willingness-to-pay